Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Chest Retrieve available abstracts of 149 articles: HTML format

Single Articles

March 2023
1. KAMMER MN, Paez R
   It Doesn't Smell Like Cancer to Me: The Promise of Exhaled Breath Biomarkers for Lung Cancer Diagnosis.
   Chest. 2023;163:479-480.
   PubMed    
   
   
   
2. RENDLE KA, Vachani A
   Patient-Oriented Tools for Communicating Lung Cancer Screening Results: The First of Many Critical Components.
   Chest. 2023;163:477-478.
   PubMed    
   
   
   February 2023
3. MANYAK A, Seaburg L, Bohreer K, Kirtland SH, et al
   Invasive Procedures Associated with Lung Cancer Screening in Clinical Practice.
   Chest. 2023 Feb 11:S0012-3692(23)00190-3. doi: 10.1016/j.chest.2023.
   PubMed     Abstract available
   
   
   
4. SILVESTRI GA, Goldman L, Tanner NT, Burleson J, et al
   Outcomes from more than a million persons screened for lung cancer with low-dose computed tomography.
   Chest. 2023 Feb 9:S0012-3692(23)00175-7. doi: 10.1016/j.chest.2023.
   PubMed     Abstract available
   
   
   
5. WEIR-MCCALL JR, Debruyn E, Harris S, Qureshi NR, et al
   Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging.
   Chest. 2023;163:444-454.
   PubMed     Abstract available
   
   
   
6. WILLIAMS PJ, Philip KEJ, Gill NK, Flannery D, et al
   Immediate, Remote Smoking Cessation Intervention in Participants Undergoing a Targeted Lung Health Check: Quit Smoking Lung Health Intervention Trial, a Randomized Controlled Trial.
   Chest. 2023;163:455-463.
   PubMed     Abstract available
   
   
   January 2023
7. GYSLING S, Morgan H, Ifesemen O, West D, et al
   The Impact of Covid-19 on Lung Cancer Incidence in England: Analysis of the National Lung Cancer Audit 2019 and 2020 Rapid Cancer Registration Datasets.
   Chest. 2023 Jan 11:S0012-3692(23)00042-9. doi: 10.1016/j.chest.2023.
   PubMed     Abstract available
   
   
   
8. JIN R, Zhang Z, Zheng Y, Niu Z, et al
   Health-Related Quality of Life following Robotic-Assisted or Video-Assisted Lobectomy in Patients with Non-Small-Cell Lung Cancer: Results from The RVlob Randomized Clinical Trial.
   Chest. 2023 Jan 5:S0012-3692(23)00015-6. doi: 10.1016/j.chest.2022.
   PubMed     Abstract available
   
   
   
9. WELCH HG, Silvestri GA
   Why Are Women More Likely to Be Overdiagnosed With Lung Cancer?
   Chest. 2023;163:22-24.
   PubMed    
   
   
   
10. ISHIWATA T, Sage AT, Fujino K, Mohammed N, et al
    A Biomarker-Based Approach for the Determination of Sample Adequacy During Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Proof of Concept Study.
    Chest. 2023;163:255-258.
    PubMed    
    
    
    December 2022
11. PINSKY P, Miller E, Faris N, Osarogiagbon R, et al
    Pulmonary Nodules, Lung Cancer Screening and Lung Cancer in the Medicare Population.
    Chest. 2022 Dec 15:S0012-3692(22)04230-1. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
12. CORTINAS N, Liu J, Kopras E, Memon H, et al
    Impact of Age, Menopause, and Sirolimus on Spontaneous Pneumothoraces in Lymphangioleiomyomatosis.
    Chest. 2022;162:1324-1327.
    PubMed    
    
    
    November 2022
13. RICHMOND J, Murray MH, Milder CM, Blume JD, et al
    Racial Disparities in Lung Cancer Stage of Diagnosis among Adults Living in the Southeastern U.S.
    Chest. 2022 Nov 23:S0012-3692(22)04195-2. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
14. SALUJA P, Patel V, Gautam N, Caceres JD, et al
    A 72-Year-Old Woman With Dyspnea, Multiple Pulmonary Nodules, and Mediastinal Lymphadenopathy.
    Chest. 2022;162:e253-e257.
    PubMed     Abstract available
    
    
    
15. POSSICK JD
    Welcome to the Real World: Understanding the Many Faces of Osimertinib-Related Pneumonitis.
    Chest. 2022;162:965-967.
    PubMed    
    
    
    
16. URUGA H, Mino-Kenudson M
    Preoperative Biopsy Does Not Generate STAS?
    Chest. 2022;162:963-964.
    PubMed    
    
    
    October 2022
17. KORT S, Brusse-Keizer M, Schouwink DH, Citgez E, et al
    Diagnosing non-small cell lung cancer by exhaled-breath profiling using an electronic nose: a multicentre validation study.
    Chest. 2022 Oct 12. pii: S0012-3692(22)03914-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
18. CROTHERS K, Shahrir S, Kross EK, Kava CM, et al
    Patient and clinician recommendations to improve communication and understanding of lung cancer screening results.
    Chest. 2022 Oct 6. pii: S0012-3692(22)03908-3. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
19. NANA-SINKAM P
    Veterans' Health Administration: A Road to Health Equity in Lung Cancer Care?
    Chest. 2022;162:742-743.
    PubMed    
    
    
    September 2022
20. FARJAH F, Monsell SE, Greenlee RT, Gould MK, et al
    Patient and Nodule Characteristics Associated with a Lung Cancer Diagnosis Among Individuals with Incidentally Detected Lung Nodules.
    Chest. 2022 Sep 30. pii: S0012-3692(22)03900-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
21. THOMAS NA, Ward R, Tanner NT, Rojewski AM, et al
    Factors Associated with Smoking Cessation Attempts in Lung Cancer Screening: A Secondary Analysis of the National Lung Screening Trial.
    Chest. 2022 Sep 23. pii: S0012-3692(22)03885.
    PubMed     Abstract available
    
    
    
22. EBERTH JM
    One Step Forward, Two Steps Back: Progress and Challenges to Implementation of Lung Cancer Screening.
    Chest. 2022;162:505-506.
    PubMed    
    
    
    
23. ROMATOWSKI NPJ, Gillson AM, Stollery D, Dumoulin E, et al
    Endobronchial Ultrasound Transbronchial Needle Aspiration With a 19-Gauge Needle vs 21- and 22-Gauge Needles for Mediastinal Lymphadenopathy.
    Chest. 2022;162:712-720.
    PubMed     Abstract available
    
    
    August 2022
24. WANG M, Lin S, He N, Yang C, et al
    The Introduction of Low-dose Computed Tomography and Lung Cancer Overdiagnosis in Chinese Women.
    Chest. 2022 Aug 20. pii: S0012-3692(22)03650.
    PubMed     Abstract available
    
    
    
25. STUDTS JL, Hirsch EA, Silvestri GA
    Shared Decision Making During a Lung Cancer Screening Visit: Is it a Barrier or Does it Bring Value?
    Chest. 2022 Aug 5. pii: S0012-3692(22)01356-3. doi: 10.1016/j.chest.2022.
    PubMed    
    
    
    
26. BURKS AC, Long J, Rivera MP
    Balancing the Benefits and Harms of Lung Cancer Screening: Much Work to Be Done.
    Chest. 2022;162:274-276.
    PubMed    
    
    
    July 2022
27. MATSUMOTO K, Shiroyama T, Yamamoto Y, Miyake K, et al
    Impact of the Treatment Line on the Risks and Benefits of Immune Checkpoint Inhibitors in Patients With Non-Small Cell Lung Cancer and Interstitial Lung Disease.
    Chest. 2022;162:e67-e69.
    PubMed    
    
    
    
28. IKEDA S, Misumi T, Kato T, Okamoto H, et al
    Immune Checkpoint Inhibitor-Induced Pneumonitis in Patients With Non-Small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: Really Mild and Easily Manageable?
    Chest. 2022;162:e65-e66.
    PubMed    
    
    
    
29. SAKODA LC, Gould MK
    Facilitating Adherence to Annual Screening for Lung Cancer: Are Program-Level Interventions Enough?
    Chest. 2022;162:8-10.
    PubMed    
    
    
    
30. KAMMER MN, Heideman BE, Maldonado F
    Should We Start With Navigation or Endobronchial Ultrasound Bronchoscopy?: Insights From Monte Carlo Simulations.
    Chest. 2022;162:265-268.
    PubMed    
    
    
    June 2022
31. JAGER EC, de Boer WS, van Schaik ML, Tomlow B, et al
    A 79-Year-Old Woman With Advanced Lung Carcinoma and Bilateral Infiltrates.
    Chest. 2022;161:e355-e358.
    PubMed     Abstract available
    
    
    
32. SATO Y, Sumikawa H, Shibaki R, Morimoto T, et al
    Drug-related pneumonitis induced by osimertinib as first-line treatment for EGFR-positive non-small cell lung cancer: a real-world setting.
    Chest. 2022 Jun 1. pii: S0012-3692(22)01068-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
33. STELIGA MA
    Smoking Cessation Impacts Survival: A Necessary Component of Cancer Care.
    Chest. 2022;161:1442-1443.
    PubMed    
    
    
    
34. BALDI BG, Radzikowska E, Cottin V, Dilling DF, et al
    COVID-19 in Lymphangioleiomyomatosis: An International Study of Outcomes and Impact of Mechanistic Target of Rapamycin Inhibition.
    Chest. 2022;161:1589-1593.
    PubMed    
    
    
    May 2022
35. WONG JYY, Cawthon R, Hu W, Ezennia S, et al
    Alu retroelement copy number and lung cancer risk in the prospective Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Chest. 2022 May 21. pii: S0012-3692(22)01003-0. doi: 10.1016/j.chest.2022.
    PubMed    
    
    
    
36. LEE GY, Chung JH, Cho S, Han YB, et al
    Impact of preoperative diagnostic biopsy procedure on spread through air spaces and related outcomes in resected stage I non-small cell lung cancer.
    Chest. 2022 May 10. pii: S0012-3692(22)00897-2. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
37. OST DE
    Criteria for Effective Definitions of Centrally Located Tumors: Practical, Predictive, and Reproducible.
    Chest. 2022;161:1140-1142.
    PubMed    
    
    
    
38. VACHANI A, Maldonado F, Laxmanan B, Kalsekar I, et al
    The Impact of Alternative Approaches to Diagnostic Yield Calculation in Studies of Bronchoscopy.
    Chest. 2022;161:1426-1428.
    PubMed    
    
    
    April 2022
39. LEWIS JA, Samuels LR, Denton J, Matheny ME, et al
    The Association of Healthcare System Resources with Lung Cancer Screening Implementation: A Cohort Study.
    Chest. 2022 Apr 9. pii: S0012-3692(22)00603-1. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
40. HEIDEN BT, Eaton DB Jr, Chang SH, Yan Y, et al
    Racial Disparities in the Surgical Treatment of Clinical Stage I Non-small Cell Lung Cancer Among Veterans.
    Chest. 2022 Apr 8. pii: S0012-3692(22)00591-8. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    March 2022
41. PINSKY PF, Miller E
    Use and Outcomes of Low-Dose CT Lung Cancer Screening in the Medicare Population.
    Chest. 2022 Mar 29. pii: S0012-3692(22)00575-X. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
42. LEE HW, Lee HJ, Lee JK, Park TY, et al
    Rapid FEV1 decline and lung cancer incidence in Korea.
    Chest. 2022 Mar 19. pii: S0012-3692(22)00452-4. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
43. POULOSE V
    Incidence of Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer.
    Chest. 2022;161:e196-e197.
    PubMed    
    
    
    
44. SAMSON P, Robinson C
    Tempering Steel With Fire: A Winning Combination for Patients With Early Stage Lung Cancer.
    Chest. 2022;161:603-604.
    PubMed    
    
    
    
45. KOUROUNI I, Han K, Glaab J, Khalid F, et al
    A 62-Year-Old Woman With Nodules, Cysts, and Activated Bone Marrow.
    Chest. 2022;161:e175-e180.
    PubMed     Abstract available
    
    
    
46. RUDNAY M, Blicharova A, Krupka M, Paranicova I, et al
    Large Thoracic Lymphadenopathy and Pulmonary Nodules in Young Man.
    Chest. 2022;161:e169-e173.
    PubMed     Abstract available
    
    
    February 2022
47. NUNEZ ER, Caverly TJ, Zhang S, Glickman ME, et al
    Invasive Procedures and Associated Complications Following Initial Lung Cancer Screening in a National Cohort of Veterans.
    Chest. 2022 Feb 26. pii: S0012-3692(22)00397-X. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
48. KLARA K, Leonardo B, Navani N, Vito D, et al
    Frailty in patients with lung cancer: a systematic review and meta-analysis.
    Chest. 2022 Feb 22. pii: S0012-3692(22)00391-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
49. HOLMAN A, Kross E, Crothers K, Cole A, et al
    Patient perspectives on longitudinal adherence to lung cancer screening.
    Chest. 2022 Feb 8. pii: S0012-3692(22)00223-9. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
50. MEADOWS-TAYLOR MB, Faris NR, Smeltzer MP, Ray MA, et al
    The Relative Survival Impact of Guideline-Concordant Clinical Staging and Stage-Appropriate Treatment of Potentially Curable Non-Small Cell Lung Cancer.
    Chest. 2022 Feb 2. pii: S0012-3692(22)00213-6. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
51. KALCHIEM-DEKEL O, Connolly JG, Lin IH, Husta BC, et al
    Shape-Sensing Robotic-Assisted Bronchoscopy in the Diagnosis of Pulmonary Parenchymal Lesions.
    Chest. 2022;161:572-582.
    PubMed     Abstract available
    
    
    January 2022
52. LIU BY, Rehmani S, Kale MS, Marshall D, et al
    Risk of Cardiovascular Toxicity According to Tumor Laterality Among Older Early Stage Non-small Cell Lung Cancer Patients Treated with Radiation Therapy.
    Chest. 2022 Jan 18. pii: S0012-3692(22)00050-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
53. LASHARI BH, Kumaran M, Aneja A, Bull T, et al
    BEYOND CLOTS IN THE PULMONARY CIRCULATION; PULMONARY ARTERY TUMORS MIMICKING PULMONARY EMBOLISM.
    Chest. 2022 Jan 15. pii: S0012-3692(22)00048-4. doi: 10.1016/j.chest.2022.
    PubMed     Abstract available
    
    
    
54. TANOUE LT, Sather P, Cortopassi I, Dicks D, et al
    Standardizing the Reporting of Incidental, Non-Lung Cancer (Category S) Findings Identified on Lung Cancer Screening Low Dose Computed Tomography.
    Chest. 2022 Jan 12. pii: S0012-3692(22)00035-6. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
55. HUANG J, Deng Y, Tin MS, Lok V, et al
    Distribution, Risk Factors, and Temporal Trends for Lung Cancer Incidence and Mortality: a global analysis.
    Chest. 2022 Jan 10. pii: S0012-3692(22)00017-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
56. ZHANG M, Fan Y, Nie L, Wang G, et al
    Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients with Advanced Non-Small Cell Lung Cancer and Pre-existing Interstitial Lung Diseases: A Systematic Review and Meta-Analysis.
    Chest. 2022 Jan 10. pii: S0012-3692(22)00018-6. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
57. BARTA JA
    Variation in Adherence to Lung Cancer Screening Among Vulnerable Populations.
    Chest. 2022;161:16-17.
    PubMed    
    
    
    
58. FITZGERALD DB, Blakey JD, Joshi P, Kuok YJ, et al
    Ultrasound Clues in Lobar Pneumonia.
    Chest. 2022;161:e59-e62.
    PubMed    
    
    
    
59. BALLENBERGER M, Vojnic M, Indaram M, Machnicki S, et al
    A 33-Year-Old Man With Chest Pain.
    Chest. 2022;161:e43-e49.
    PubMed     Abstract available
    
    
    December 2021
60. JALLOW M, Bonfield S, Kurtidu C, Baldwin DR, et al
    Decision support tools for low dose computed tomography (LDCT) lung cancer screening: a scoping review of information content, format, and presentation methods.
    Chest. 2021 Dec 16. pii: S0012-3692(21)05089-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
61. HEIDEN BT, Eaton DB Jr, Chang SH, Yan Y, et al
    The impact of persistent smoking after surgery on long-term outcomes following stage I non-small cell lung cancer resection.
    Chest. 2021 Dec 14. pii: S0012-3692(21)05082-0. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
62. HWANGBO B, Park EY, Yang B, Lee GK, et al
    Long-Term Survival According to N Stage Diagnosed by Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration in Non-Small Cell Lung Cancer.
    Chest. 2021 Dec 8. pii: S0012-3692(21)04434-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
63. PERVAIZ A, Inany M, Nguyen HQ, Jacques SM, et al
    A Pregnant Woman With Hemoptysis and Diffuse Pulmonary Nodules.
    Chest. 2021;160:e651-e656.
    PubMed     Abstract available
    
    
    
64. GUPTA S, Parmar M, Cox C, Orabi C, et al
    Interlobular Septal Thickening in a Young Man With Dyspnea.
    Chest. 2021;160:e645-e650.
    PubMed     Abstract available
    
    
    
65. SINGH H, Jani CT, Abdalla M, Puzyrenko A, et al
    A 39-Year-Old Woman With Synchronous Endobronchial and Adrenal Tumors.
    Chest. 2021;160:e629-e632.
    PubMed     Abstract available
    
    
    
66. FOO CT, Paterson A, Duckworth A, Herre J, et al
    Intrapleural Hyaluronidase in Viscous Malignant Mesothelioma Pleural Effusion.
    Chest. 2021;160:e609-e611.
    PubMed     Abstract available
    
    
    November 2021
67. PINSKY PF, Lynch DA, Gierada DS
    Incidental Findings on Low-Dose CT Lung Cancer Screenings and Deaths from Respiratory Diseases.
    Chest. 2021 Nov 24. pii: S0012-3692(21)04413-5. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
68. HENDERSON LM, Farjah F, Detterbeck F, Smith RA, et al
    Pretreatment Invasive Nodal Staging in Lung Cancer: Knowledge, Attitudes, and Beliefs among Academic and Community Physicians.
    Chest. 2021 Nov 18. pii: S0012-3692(21)04376-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
69. KIM H, Choi H, Lee KH, Cho S, et al
    Definitions of Central Tumors in Radiologically Node-negative, Early-stage Lung Cancer for Preoperative Mediastinal Lymph Node Staging: A Dual-institution, Multi-reader Study.
    Chest. 2021 Nov 13. pii: S0012-3692(21)04288-4. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
70. SYED YA, Stokes W, Rupji M, Liu Y, et al
    Surgical Outcomes for Early-Stage Non-Small Cell Lung Cancer at Facilities with Stereotactic Body Radiation Therapy Programs.
    Chest. 2021 Nov 13. pii: S0012-3692(21)04287-2. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
71. MURUGANANDAN S, Duong V
    Malignant Pleural Effusion in Malignant Pleural Mesothelioma: An Innocent Bystander?
    Chest. 2021;160:1602-1603.
    PubMed    
    
    
    
72. GAO X, Yu Y, Zhou T, Shu H, et al
    A Young Woman With Severe Hypotension After Right Lung Lobectomy.
    Chest. 2021;160:e535-e537.
    PubMed    
    
    
    
73. BALTAJI S, Rabold E, Balikani L, Mickus T, et al
    Case of a 57-Year-Old Man With Malignant Mesothelioma Presenting With Miliary Nodules on Chest Imaging.
    Chest. 2021;160:e523-e526.
    PubMed     Abstract available
    
    
    
74. FAKILI F, Duzen IV, Kaplan M, Bayram NG, et al
    A 24-Year-Old Woman With Dyspnea, Chest Pain, and Dry Cough.
    Chest. 2021;160:e503-e506.
    PubMed     Abstract available
    
    
    
75. ASCIAK R, Kanellakis NI, Bibby A, Kidd A, et al
    The Association Between Pleural Fluid Exposure and Survival in Pleural Mesothelioma.
    Chest. 2021;160:1925-1933.
    PubMed     Abstract available
    
    
    
76. ZHENG C, Huang BZ, Agazaryan AA, Creekmur B, et al
    Natural Language Processing to Identify Pulmonary Nodules and Extract Nodule Characteristics From Radiology Reports.
    Chest. 2021;160:1902-1914.
    PubMed     Abstract available
    
    
    
77. MATSUMOTO Y, Nakai T, Tanaka M, Imabayashi T, et al
    Diagnostic Outcomes and Safety of Cryobiopsy Added to Conventional Sampling Methods: An Observational Study.
    Chest. 2021;160:1890-1901.
    PubMed     Abstract available
    
    
    October 2021
78. GOTO T
    Cell-Free DNA From Nontumor Tissue in Patients With Non-small Cell Lung Cancer.
    Chest. 2021;160:e374-e375.
    PubMed    
    
    
    
79. CANDAL-PEDREIRA C, Ruano-Ravina A, Provencio M, Fernandez-Villar A, et al
    Lung Cancer Screening Quality Criteria: A Population Perspective.
    Chest. 2021;160:e329-e331.
    PubMed    
    
    
    
80. ARABIAT M, Bhat P, Steff R, Singh K, et al
    A 56-Year-Old Woman With Nonresolving Pneumonia.
    Chest. 2021;160:e369-e370.
    PubMed    
    
    
    
81. FORBES LM, Hensley ND, Miller YE
    A 58-Year-Old Woman With a History of Cardiac Myxoma Presents With Pulmonary Nodules.
    Chest. 2021;160:e351-e355.
    PubMed     Abstract available
    
    
    
82. MARCIANO BE, Olivier KN, Folio LR, Zerbe CS, et al
    Pulmonary Manifestations of GATA2 Deficiency.
    Chest. 2021;160:1350-1359.
    PubMed     Abstract available
    
    
    
83. MUMMADI SR, Stoller JK, Lopez R, Kailasam K, et al
    Epidemiology of Adult Pleural Disease in the United States.
    Chest. 2021;160:1534-1551.
    PubMed     Abstract available
    
    
    
84. HERTH FJ, Mayer M, Thiboutot J, Kapp CM, et al
    Safety and Performance of Transbronchial Cryobiopsy for Parenchymal Lung Lesions.
    Chest. 2021;160:1512-1519.
    PubMed     Abstract available
    
    
    September 2021
85. SMITH HB, Ward R, Frazier C, Angotti J, et al
    Guideline Recommended Lung Cancer Screening Adherence is Superior with Centralized Approach.
    Chest. 2021 Sep 15. pii: S0012-3692(21)03856-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
86. SLATORE CG, Golden SE, Thomas T, Patzel M, et al
    Beliefs and Practices of Primary Care Providers regarding Performing Low-Dose Computed Tomography Studies for Lung Cancer Screening.
    Chest. 2021 Sep 1. pii: S0012-3692(21)03834-4. doi: 10.1016/j.chest.2021.
    PubMed    
    
    
    
87. KRAMER T, Manley CJ, Annema JT
    Robotic Bronchoscopy for Diagnosing Peripheral Lung Lesions: Are We There Yet?
    Chest. 2021;160:e326-e327.
    PubMed    
    
    
    
88. TZILAS V, Bouros D
    A 58-Year-Old Woman With Lung Nodules and Chronic Cough.
    Chest. 2021;160:e285-e288.
    PubMed     Abstract available
    
    
    
89. MANOUKIAN MAC, Corbett RL, Mumma BE, Darrow MA, et al
    A 70-Year-Old Woman With Refractory Hypoxemia.
    Chest. 2021;160:e265-e268.
    PubMed     Abstract available
    
    
    August 2021
90. SAINZ ZUNIGA PV, Ost DE
    Impact of Delays in Lung Cancer Treatment on Survival.
    Chest. 2021 Aug 20. pii: S0012-3692(21)03689-8. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
91. KUNITOMO Y, Bade B, Gunderson CG, Akgun KM, et al
    Racial Differences in Adherence to Lung Cancer Screening Follow-Up: A Systematic Review and Meta-Analysis.
    Chest. 2021 Aug 11. pii: S0012-3692(21)03664.
    PubMed     Abstract available
    
    
    
92. VACHANI A, Zheng C, Amy Liu IL, Huang BZ, et al
    The probability of lung cancer in patients with incidentally detected pulmonary nodules: clinical characteristics and accuracy of prediction models.
    Chest. 2021 Aug 5. pii: S0012-3692(21)03624-2. doi: 10.1016/j.chest.2021.07.2168
    PubMed     Abstract available
    
    
    
93. ZELIADT SB
    Smoking Cessation Resources Can and Should Be Integrated in Lung Cancer Screening.
    Chest. 2021;160:413-414.
    PubMed    
    
    
    
94. OMBALLI M, Ramaniuk A, Patel DC, Ataya A, et al
    A 29-Year-Old Woman With Cough, Dry Eyes, Pulmonary Cysts, and Nodules.
    Chest. 2021;160:e195-e198.
    PubMed     Abstract available
    
    
    July 2021
95. TANDJAOUI-LAMBIOTTE Y, Akrour Y, Gibelin A, Gonzalez F, et al
    Tyrosine kinase inhibitors for acute respiratory failure due to non-small-cell lung cancer involvement in intensive care unit.
    Chest. 2021 Jul 21. pii: S0012-3692(21)01358-1. doi: 10.1016/j.chest.2021.
    PubMed    
    
    
    
96. FEDEWA SA, Bandi P, Smith RA, Silvestri GA, et al
    Lung Cancer Screening Rates During the COVID-19 Pandemic.
    Chest. 2021 Jul 20. pii: S0012-3692(21)01364-7. doi: 10.1016/j.chest.2021.
    PubMed    
    
    
    
97. VAKIL E, Jackson N, Sainz-Zunega PV, Molina S, et al
    Optimizing diagnostic and staging pathways for suspected lung cancer: a decision analysis.
    Chest. 2021 Jul 10. pii: S0012-3692(21)01314-3. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
98. MAZZONE PJ, Silvestri GA, Souter LH, Caverly TJ, et al
    Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01307-6. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
99. MAZZONE PJ, Silvestri GA, Souter LH, Caverly TJ, et al
    Screening for Lung Cancer: CHEST Guideline and Expert Panel Report - Executive Summary.
    Chest. 2021 Jul 9. pii: S0012-3692(21)01304-0. doi: 10.1016/j.chest.2021.
    PubMed     Abstract available
    
    
    
100. BUEHLER KE, Wilshire CL, Gilbert CR, Gorden JA, et al
     Imaging Administrators: The Overlooked Barrier to Lung Cancer Screening Implementation.
     Chest. 2021 Jul 9. pii: S0012-3692(21)01313-1. doi: 10.1016/j.chest.2021.
     PubMed    
     
     
     
101. PASQUINELLI MM, Tammemagi MC, Kovitz KL, Durham ML, et al
     Addressing Gender Disparities in Lung Cancer Screening Eligibility: USPSTF versus PLCOm2012 Criteria.
     Chest. 2021 Jul 9. pii: S0012-3692(21)01316-7. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
102. SEARS CR, Rivera MP
     Age, Sex, Smoking, and Race: Is Progress Being Made in Lung Cancer Screening Eligibility?
     Chest. 2021;160:31-33.
     PubMed    
     
     
     
103. WATABE Y, Ujiie H, Matsuno Y, Fukui H, et al
     Rare Diagnosis of a Multilobular Pulmonary Mass.
     Chest. 2021;160:e63-e67.
     PubMed     Abstract available
     
     
     
104. PERLEPE G, Karetsi E, Papamichali R, Papadopoulos D, et al
     A 72-Year-Old Woman With Multiple Pulmonary Nodules and a History of Malignancy.
     Chest. 2021;160:e57-e61.
     PubMed     Abstract available
     
     
     
105. SAHA BK, Bonnier A, Chong WH, Chieng H, et al
     A 75-Year-Old Woman With Pulmonary Nodules and Dyspnea.
     Chest. 2021;160:e51-e56.
     PubMed     Abstract available
     
     
     
106. DESAI NR, Gildea TR, Kessler E, Ninan N, et al
     Advanced Diagnostic and Therapeutic Bronchoscopy: Technology and Reimbursement.
     Chest. 2021;160:259-267.
     PubMed     Abstract available
     
     
     
107. MATTHEW BP, Hasani AM, Chen YC, Pirooznia M, et al
     Ultra-Small Lung Cysts Impair Diffusion Without Obstructing Air Flow in Lymphangioleiomyomatosis.
     Chest. 2021;160:199-208.
     PubMed     Abstract available
     
     
     June 2021
108. FOX AH, Jett JR, Roy UB, Johnson BE, et al
     Knowledge and Practice Patterns Among Pulmonologists for Molecular Biomarker Testing in Advanced Non-Small Cell Lung Cancer.
     Chest. 2021 Jun 25. pii: S0012-3692(21)01253-8. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
109. GUINDE J, Bourdages-Pageau E, Collin-Castonguay MM, Laflamme L, et al
     A Prediction Model to Optimize Invasive Mediastinal Staging Procedures for Non-Small Cell Lung Cancer in Patients with a Radiologically Normal Mediastinum: the Quebec Prediction Model.
     Chest. 2021 Jun 10. pii: S0012-3692(21)01103-X. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
110. LAMPRIDIS S
     Differences in Staging and Treating Patients With Locally Advanced Non-small Cell Lung Cancer.
     Chest. 2021;159:2518-2519.
     PubMed    
     
     
     
111. HYLTON DA, Kidane B, Spicer J, Turner S, et al
     Endobronchial Ultrasound Staging of Operable Non-small Cell Lung Cancer: Do Triple-Normal Lymph Nodes Require Routine Biopsy?
     Chest. 2021;159:2470-2476.
     PubMed     Abstract available
     
     
     
112. VAN GERPEN R
     Creating an Incidental Pulmonary Nodule Safety-Net Program.
     Chest. 2021;159:2477-2482.
     PubMed     Abstract available
     
     
     
113. CHIENG H, Saha B, Itty R, Foulke L, et al
     A 67-Year-Old Woman With Progressive Dyspnea and Innumerous Pulmonary Nodules.
     Chest. 2021;159:e395-e401.
     PubMed     Abstract available
     
     
     
114. KINOSHITA Y, Ikeda T, Ueda Y, Sasaki T, et al
     A 63-Year-Old Woman With an Acute Exacerbation of Interstitial Pneumonia.
     Chest. 2021;159:e389-e394.
     PubMed     Abstract available
     
     
     May 2021
115. FARJAH F, Tanner NT
     How I Do It: Mediastinal Staging for Lung Cancer.
     Chest. 2021 May 21. pii: S0012-3692(21)00900-4. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
116. LI F, Yuan L, Zhao Y, Wang S, et al
     Comparison of two proposed changes to the current nodal classification for non-small cell lung cancer based on the number and ratio of metastatic lymph nodes.
     Chest. 2021 May 21. pii: S0012-3692(21)00907-7. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
117. VIGNERON C, Charpentier J, Wislez M, Mira JP, et al
     Short-term and long-term outcomes of patients with lung cancer and life-threatening complications.
     Chest. 2021 May 4. pii: S0012-3692(21)00864-3. doi: 10.1016/j.chest.2021.
     PubMed    
     
     
     
118. GOTO T
     Women Fare Better After Lung-Cancer Surgery: What Does This Mean for Clinical Practice?
     Chest. 2021;159:2119-2120.
     PubMed    
     
     
     
119. MACROSTY CR, Rivera MP
     Increased Risk and Improved Survival: The Double-Edged Sword of Lung Cancer in Women.
     Chest. 2021;159:1719-1720.
     PubMed    
     
     
     
120. MASCALCHI M, Luconi M
     Lung Cancer Screening, Emphysema, and COPD.
     Chest. 2021;159:1699-1700.
     PubMed    
     
     
     
121. SCHARNETZKI L, Schiller JH
     Lung Cancer: Why the Stigma? And What Can Be Done?
     Chest. 2021;159:1721-1722.
     PubMed    
     
     
     
122. TRIANTAFYLLIDOU C, Effraimidis P, Schimanke M, Ignatova S, et al
     A Well-Defined Endobronchial Tumor in a 26-Year-Old Man.
     Chest. 2021;159:e313-e317.
     PubMed     Abstract available
     
     
     
123. AZOUR L, Ko JP, Naidich DP, Moore WH, et al
     Shades of Gray: Subsolid Nodule Considerations and Management.
     Chest. 2021;159:2072-2089.
     PubMed     Abstract available
     
     
     April 2021
124. MARTINEZ-ZAYAS G, Almeida FA, Yarmus L, Steinfort D, et al
     Predicting Lymph Node Metastasis in Non-Small Cell Lung Cancer: Prospective External and Temporal Validation of the HAL and HOMER Models.
     Chest. 2021 Apr 28. pii: S0012-3692(21)00856-4. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
125. RIVERA MP, Charlot M, Durham DD, Throneburg A, et al
     Molecular Biomarker and Program Death-Ligand 1 Expression Testing in Patients with Advanced Stage Non-Small Cell Lung Cancer Across North Carolina Community Hospitals.
     Chest. 2021 Apr 19. pii: S0012-3692(21)00702-9. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
126. ROOSAN MR, Mambetsariev I, Pharaon R, Fricke J, et al
     Utility of Circulating Tumor DNA in Identifying Somatic Mutations and Tracking Tumor Evolution in Patients with Non-small Cell Lung Cancer.
     Chest. 2021 Apr 17. pii: S0012-3692(21)00705-4. doi: 10.1016/j.chest.2021.
     PubMed     Abstract available
     
     
     
127. RAJARAM R
     Hospital Variation in Long-Term Survival After Lung Cancer Surgery.
     Chest. 2021;159:1330-1331.
     PubMed    
     
     
     
128. LONG JM
     Cutting Corners in the Mediastinum: Should Contralateral Hilar N3 Nodes Be Omitted From Staging?
     Chest. 2021;159:1328-1329.
     PubMed    
     
     
     
129. BENZAQUEN S, Kaini N, Gupta E, Litwin D, et al
     Women Presenting With Asthma and Persistent Wheezing: A Case Series.
     Chest. 2021;159:e267-e275.
     PubMed    
     
     
     
130. STERN KM, Ries S, Beltran A, Youssef FA, et al
     A 51-Year-Old Woman With Rapidly Progressive Dyspnea.
     Chest. 2021;159:e251-e255.
     PubMed     Abstract available
     
     
     
131. ROY AM, Venkata AN, Yadala S
     A 44-Year-Old Woman With a 10-Year History of Dyspnea and Pulmonary Nodules.
     Chest. 2021;159:e247-e250.
     PubMed     Abstract available
     
     
     
132. IDO F, Purdy A, Harrison MA, Longo S, et al
     Shortness of Breath in a 38-Year-Old Woman With Pulmonary and Hepatic Nodules.
     Chest. 2021;159:e261-e266.
     PubMed     Abstract available
     
     
     
133. SAINZ ZUNIGA PV, Martinez-Zayas G, Molina S, Grosu HB, et al
     Is Biopsy of Contralateral Hilar N3 Lymph Nodes With Negative PET-CT Scan Findings Necessary When Performing Endobronchial Ultrasound Staging?
     Chest. 2021;159:1642-1651.
     PubMed     Abstract available
     
     
     March 2021
134. CHONG WH, Ibrahim A, Saha BK
     A 69-Year-Old Woman With Ulcerative Colitis and Pulmonary Nodules.
     Chest. 2021;159:e147-e150.
     PubMed     Abstract available
     
     
     
135. SUNDARAM V, Gould MK, Nair VS
     A Comparison of the PanCan Model and Lung-RADS to Assess Cancer Probability Among People With Screening-Detected, Solid Lung Nodules.
     Chest. 2021;159:1273-1282.
     PubMed     Abstract available
     
     
     
136. ZHANG Y, Deng C, Fu F, Ma Z, et al
     Excellent Prognosis of Patients With Invasive Lung Adenocarcinomas During Surgery Misdiagnosed as Atypical Adenomatous Hyperplasia, Adenocarcinoma In Situ, or Minimally Invasive Adenocarcinoma by Frozen Section.
     Chest. 2021;159:1265-1272.
     PubMed     Abstract available
     
     
     
137. TANNER NT, Springmeyer SC, Porter A, Jett JR, et al
     Assessment of Integrated Classifier's Ability to Distinguish Benign From Malignant Lung Nodules: Extended Analyses and 2-Year Follow-Up Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial.
     Chest. 2021;159:1283-1287.
     PubMed    
     
     
     February 2021
138. HUI SLY, Haja Mohideen SM, Cheng XM, Chew SY, et al
     Chronic Cough With Non-Resolving Mass-like Consolidation.
     Chest. 2021;159:e119-e126.
     PubMed     Abstract available
     
     
     
139. CHUAN TY, Mun WL, Siang WH
     An 86-Year-Old Woman Presenting With 2 Weeks of Worsening Dyspnea and Cough.
     Chest. 2021;159:e103-e106.
     PubMed     Abstract available
     
     
     
140. CHEN AC, Pastis NJ Jr, Mahajan AK, Khandhar SJ, et al
     Robotic Bronchoscopy for Peripheral Pulmonary Lesions: A Multicenter Pilot and Feasibility Study (BENEFIT).
     Chest. 2021;159:845-852.
     PubMed     Abstract available
     
     
     January 2021
141. ENDICOTT-YAZDANI TR, Baird RW, Koch MS, Moore AJ, et al
     A 55-Year-Old Woman With Frequent Pulmonary Exacerbations and Endobronchial Lesions.
     Chest. 2021;159:e49-e52.
     PubMed     Abstract available
     
     
     
142. MAYER N, Carboni GL, Thielken A, Wagnetz D, et al
     Sclerosing Pneumocytoma: A Host for a Typical Carcinoid With Pleural Metastasis-A Wolf in Sheep`s Clothing.
     Chest. 2021;159:e1-e5.
     PubMed     Abstract available
     
     
     
143. DUCOMB EA, Kinsey CM
     Response.
     Chest. 2021;159:447-448.
     PubMed    
     
     
     
144. ROY P, Fortin M
     Should We Expand Invasive Mediastinal Staging to Peripheral T1 Lung Tumors?
     Chest. 2021;159:446-447.
     PubMed    
     
     
     
145. RAMAN V, Jawitz OK, D'Amico TA, Yang CJ, et al
     Response.
     Chest. 2021;159:445-446.
     PubMed    
     
     
     
146. ABOUDARA M, Rickman OB, Maldonado F
     An Evaluation of Bronchoscopy Diagnostic Yield: Should We Only Be Doing EBUS?
     Chest. 2021;159:437-438.
     PubMed    
     
     
     
147. ALMQUIST DR, Sonbol MB, Ross HJ, Kosiorek H, et al
     Clinical Characteristics of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia: A Retrospective Analysis.
     Chest. 2021;159:432-434.
     PubMed    
     
     
     
148. LEE HJ, Mazzone P, Feller-Kopman D, Yarmus L, et al
     Impact of the Percepta Genomic Classifier on Clinical Management Decisions in a Multicenter Prospective Study.
     Chest. 2021;159:401-412.
     PubMed     Abstract available
     
     
     June 2020
149. SAGAR AS, Sabath BF, Eapen GA, Song J, et al
     "Incidence and Location of Atelectasis Developed During Bronchoscopy Under General Anesthesia" (I-LOCATE Trial).
     Chest. 2020 Jun 16. pii: S0012-3692(20)31632-9. doi: 10.1016/j.chest.2020.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: